Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SWTX | Common Stock | Sale | -$70.3M | -1M | -17.15% | $70.25 | 4.83M | Aug 10, 2021 | See footnotes | F1, F2, F3 |
holding | SWTX | Common Stock | 1.11K | Aug 10, 2021 | Direct | F4 |
Id | Content |
---|---|
F1 | Represents shares of common stock held directly by BC SW, LP. |
F2 | Bain Capital Life Sciences Investors, LLC ("BCLSI"), whose managers are Jeffrey Schwartz and Adam Koppel, is the general partner of BC SW, LP. As a result, each of BCLSI, Mr. Schwartz and Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC SW, LP. BCLSI, Mr. Schwartz and Dr. Koppel each disclaim beneficial ownership of such securities except to the extent of its or their pecuniary interest therein. |
F3 | Jeffrey Schwartz is a director of the Issuer. |
F4 | Represents a restricted stock award held directly by Jeffrey Schwartz. |